Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Microbiome and prostate cancer: a novel target for prevention and treatment
N Kustrimovic, R Bombelli, D Baci… - International journal of …, 2023 - mdpi.com
Growing evidence of the microbiome's role in human health and disease has emerged since
the creation of the Human Microbiome Project. Recent studies suggest that alterations in …
the creation of the Human Microbiome Project. Recent studies suggest that alterations in …
[HTML][HTML] The current role of precision surgery in oligometastatic prostate cancer
M von Deimling, P Rajwa, D Tilki, A Heidenreich… - ESMO open, 2022 - Elsevier
Oligometastatic prostate cancer (omPCa) is a novel intermediate disease state
characterized by a limited volume of metastatic cells and specific locations. Accurate staging …
characterized by a limited volume of metastatic cells and specific locations. Accurate staging …
Personalizing approaches to the management of metastatic hormone sensitive prostate cancer: role of advanced imaging, genetics and therapeutics
SD Lokeshwar, AU Choksi, D Haltstuch… - World Journal of …, 2023 - Springer
Purpose To summarize contemporary and emerging strategies for the diagnosis and
management of metastatic hormone sensitive prostate cancer (mHSPC), focusing on …
management of metastatic hormone sensitive prostate cancer (mHSPC), focusing on …
An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
(1) Background: Local therapy is highly promising in a multimodal approach strategy for
patients with low-volume metastatic prostate cancer (mPCa). We aimed to systematically …
patients with low-volume metastatic prostate cancer (mPCa). We aimed to systematically …
Local therapeutics for the treatment of oligo metastatic prostate cancer
MJ Jalfon, OV Sakhalkar, SD Lokeshwar… - Current Urology …, 2023 - Springer
Abstract Purpose of Review Metastatic prostate cancer remains universally lethal. Although
de-novo metastatic prostate cancer was historically managed with systemic therapy alone …
de-novo metastatic prostate cancer was historically managed with systemic therapy alone …
Prostatectomy and other local treatments for oligometastatic prostate cancer: recent and ongoing trials
AM Fang, LP MacDonald, JR Gregg… - Current opinion in …, 2025 - journals.lww.com
Current Opinion in Urology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
Current Controversy and Developments Regarding the Cytoreductive Prostatectomy for Oligometastatic Prostate Cancer
Y Tian, Y Mao, Z Tang, M Hu - Technology in Cancer …, 2023 - journals.sagepub.com
Oligometastatic prostate cancer is a term that is most often used to refer to limited sites of
disseminated tumor growth following primary radical prostatectomy (RP) or radiotherapy …
disseminated tumor growth following primary radical prostatectomy (RP) or radiotherapy …
[HTML][HTML] Олигометастатический рак предстательной железы: локальное лечение и метастазнаправленная терапия
МД Тер-Ованесов, ДМ Ягудаев, ЕВ Аниканова… - …, 2024 - cyberleninka.ru
Статья посвящена современным методам диагностики и лечения
олигометастатического рака предстательной железы на основании анализа большого …
олигометастатического рака предстательной железы на основании анализа большого …
Zytoreduktive Prostatektomie und Metastasektomie beim metastasierten Prostatakarzinom
A Heidenreich, J Heidenreich, D Pfister - … : Diagnostik und Therapie, 2023 - Springer
Trotz der zunehmenden Wahrnehmung von Früherkennungsprogrammen weisen auch
heute noch ca. 10% der neu diagnostizierten Prostatakarzinome systemische Metastasen …
heute noch ca. 10% der neu diagnostizierten Prostatakarzinome systemische Metastasen …
Therapeutic Prognosis of Prostate Cancer by Profiling Urinary Biomakers for Personalized Treatment
Y Ma - 2022 - search.proquest.com
Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer in the US. It
is the second leading cause of cancer mortality, accounting for 20% of all cancer deaths in …
is the second leading cause of cancer mortality, accounting for 20% of all cancer deaths in …